Victoria Hargrave
Psychiatric/Mental Health · Jerseyville, ILNPI 1023259967
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 454 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 42 manufacturers reported payments, led by AbbVie at 24.7% of the total. Among psychiatric/mental health clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 454 payments — averaging $17.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$921
- Amgen$695
- Novo Nordisk$516
- Lilly USA, LLC$398
- Teva Pharmaceuticals USA, Inc.$294
- plus $3K from 36 others
What the payments were for
- Food & beverage$7,729100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,729 in reported general payments places this provider in the 95th percentile of 922 psychiatric/mental health providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SpravatoEsketamine Hcl | 123 | $147,874 |
| Austedo XrDeutetrabenazine | 11 | $55,281 |
| Invega SustennaPaliperidone Palmitate | 13 | $14,827 |
| Lurasidone Hcl | 12 | $11,574 |
| Aripiprazole | 42 | $2,344 |
| Vilazodone Hcl | 15 | $2,338 |
| Duloxetine Hcl | 33 | $1,320 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 16 | $809 |
| Lamotrigine | 21 | $431 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 25 | $414 |
| Buspirone Hcl | 11 | $393 |
| Escitalopram Oxalate | 24 | $213 |
| Trazodone Hcl | 27 | $203 |
| Fluoxetine Hcl | 28 | $140 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 11 | $78 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonSpravato, Invega Sustenna | $921 | $162,700136 claims |
| Teva Pharmaceuticals USA, Inc.Austedo Xr | $294 | $55,28111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 922 psychiatric/mental health providers in Illinois.
Other psychiatric/mental health in Jerseyville
- Erin PetrusicChicago$517K
- Maurice BrownleeChicago$151K
- Melissa VitaleChicago$151K
- Alan AmbergChicago$119K
- Jaime MendozaMaryville$111K
- Jennifer TheryMaryville$83K
- Carole Weddington HuntGranite City$67K
- Jessica WhelanBloomington$55K
- Lynn LochnerKankakee$41K
- Julie CarbrayChicago$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.